Tianjin, 300060
China
Tianjin Medical University - National Clinical Research Center for Cancer
Metastatic Breast Cancer, HR-positive, CDK4/6 inhibitor, prognostic factor, hematological indicator
Phase II study, metastatic breast cancer, HER2-positive, pyrotinib, capecitabine, metronomic chemotherapy